+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Stiffening and unfolding of early deposited-fibronectin increase proangiogenic factor secretion by breast cancer-associated stromal cells



Stiffening and unfolding of early deposited-fibronectin increase proangiogenic factor secretion by breast cancer-associated stromal cells



Biomaterials 54: 63-71



Fibronectin (Fn) forms a fibrillar network that controls cell behavior in both physiological and diseased conditions including cancer. Indeed, breast cancer-associated stromal cells not only increase the quantity of deposited Fn but also modify its conformation. However, (i) the interplay between mechanical and conformational properties of early tumor-associated Fn networks and (ii) its effect on tumor vascularization remain unclear. Here, we first used the Surface Forces Apparatus to reveal that 3T3-L1 preadipocytes exposed to tumor-secreted factors generate a stiffer Fn matrix relative to control cells. We then show that this early matrix stiffening correlates with increased molecular unfolding in Fn fibers, as determined by Förster Resonance Energy Transfer. Finally, we assessed the resulting changes in adhesion and proangiogenic factor (VEGF) secretion of newly seeded 3T3-L1s, and we examined altered integrin specificity as a potential mechanism of modified cell-matrix interactions through integrin blockers. Our data indicate that tumor-conditioned Fn decreases adhesion while enhancing VEGF secretion by preadipocytes, and that an integrin switch is responsible for such changes. Collectively, our findings suggest that simultaneous stiffening and unfolding of initially deposited tumor-conditioned Fn alters both adhesion and proangiogenic behavior of surrounding stromal cells, likely promoting vascularization and growth of the breast tumor. This work enhances our knowledge of cell - Fn matrix interactions that may be exploited for other biomaterials-based applications, including advanced tissue engineering approaches.

(PDF emailed within 0-6 h: $19.90)

Accession: 058905298

Download citation: RISBibTeXText

PMID: 25907040

DOI: 10.1016/j.biomaterials.2015.03.019


Related references

Adipose progenitor cells increase fibronectin matrix strain and unfolding in breast tumors. Physical Biology 8(1): 015008-015008, 2011

Fibronectin conformation regulates the proangiogenic capability of tumor-associated adipogenic stromal cells. Biochimica et Biophysica Acta 1830(9): 4314-4320, 2013

Estrogen increases secretion of stromal cell derived factor-1 in human breast cancer cells. International Journal of Clinical and Experimental Medicine 7(12): 5529-5534, 2015

Chemotactic and proangiogenic role of calcium sensing receptor is linked to secretion of multiple cytokines and growth factors in breast cancer MDA-MB-231 cells. Biochimica et Biophysica Acta 1853(1): 166-182, 2015

Breast cancer cells alter the dynamics of stromal fibronectin-collagen interactions. Matrix Biology, 2016

Fibronectin-Alginate microcapsules improve cell viability and protein secretion of encapsulated Factor IX-engineered human mesenchymal stromal cells. Artificial Cells, Nanomedicine, and Biotechnology 43(5): 318-327, 2016

Regulation of fibronectin and laminin receptor expression, fibronectin and laminin secretion in human colon cancer cells by transforming growth factor-beta 1. International Journal of Cancer 57(5): 742-746, 1994

Sesamin inhibits macrophage-induced vascular endothelial growth factor and matrix metalloproteinase-9 expression and proangiogenic activity in breast cancer cells. Inflammation 34(3): 209-221, 2011

Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer. Breast Cancer Research 7(4): R402-R410, 2005

Breast cancer cells increase osteoclastogenesis by secreting M-CSF and by upregulating RANKL in bone marrow stromal cells in a gp130-dependent fashion. Journal of Bone & Mineral Research 14(SUPPL 1): S153, Sept, 1999

Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion. Journal of Clinical Investigation 124(10): 4614-4628, 2015

Regulation of proangiogenic factor secretion by human dendritic cells. Proceedings of the American Association for Cancer Research Annual Meeting 42: 568, March, 2001

Berberine suppresses TPA-induced fibronectin expression through the inhibition of VEGF secretion in breast cancer cells. Cellular Physiology and Biochemistry 32(5): 1541-1550, 2014

Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF- and TGF-beta. Journal of cell science15 118(10): 2143-2153, 2005

Specific increase of human kallikrein 4 mRNA and protein levels in breast cancer stromal cells. Biochemical and Biophysical Research Communications 375(1): 107-112, 2008